文献速递系统性红斑狼疮

系统性红斑狼疮中哪种肾外发作「难以治疗」?一项比较传统方法与机器学习方法的一年纵向研究

Which extra-renal flare is 'difficult to treat' in systemic lupus erythematosus? A one-year longitudinal study comparing traditional and machine learning approaches.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

本研究描述SLE肾外发作的表型与结局,基于基线特征对发作进行聚类,并开发机器学习工具预测「难以治疗」(D2T)发作。2015至2021年间共纳入79次肾外发作,12个月时79.4%达LLDAS、49.4%达缓解,17次(21.5%)为D2T发作;3个月时未达LLDAS是D2T发作的唯一独立预测因素。

要点

  • 肾外发作以皮肤黏膜(24.1%)和肌肉骨骼(45.6%)为主,12个月时79.4%达LLDAS、49.4%达缓解。
  • 17次发作(21.5%)为D2T,D2T发作接受更高的糖皮质激素累积剂量和日剂量。
  • 聚类「D」(有皮肤受累史患者的轻中度皮肤黏膜发作)与最低缓解率相关。

核心结论

  • 聚类能根据基线特征较好地区分肾外发作,可能提出新的识别标准。
  • D2T发作尤其是难治性皮肤表现在SLE中常见,是疾病管理未满足的需求,与更高糖皮质激素剂量和损伤累积风险相关。
  • 机器学习模型可能有助于早期识别D2T发作,在入院时标记以提高关注阈值。

研究设计与样本

  • 研究纳入本队列过去五年内发生、随访至少一年的肾外发作。
  • 描述基线临床变量并对发作进行聚类,比较12个月时缓解和LLDAS的达成情况。
  • 6个月和12个月未达LLDAS的发作定义为D2T,用基线特征训练机器学习模型在入院时预测未来D2T发作。
  • 比较传统方法与信息学技术。

主要发现

  • 队列420例SLE患者中,2015至2021年间发生114次发作,其中纳入79次肾外发作。
  • 肾外发作以皮肤黏膜(24.1%)和肌肉骨骼(45.6%)为主。
  • 12个月后79.4%达LLDAS、49.4%达缓解,17次发作(21.5%)为D2T。
  • D2T发作接受更高的糖皮质激素累积剂量和日剂量。
  • 聚类「D」(有皮肤受累史患者的轻中度皮肤黏膜发作)与最低缓解率相关。

临床怎么用

  • 作者认为机器学习模型可能有助于早期识别D2T发作,在入院时标记以提高关注阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe phenotypes and outcomes of extra-renal flares in SLE, to identify clusters of extra-renal flares based on baseline features, and to develop a machine learning (ML) tool capable of predicting 'difficult to treat' (D2T) flares. METHODS: Extra-renal flares that occurred in our cohort over the last five years with at least one year of follow-up were included. Baseline clinical variables were described and flares assigned to clusters. Attainment of remission and low disease activity state (LLDAS) at 12 months were compared. Flares were then considered 'D2T' in case of non-attainment of LLDAS at 6 and 12 months. Baseline features were used to train a ML model able to predict future D2T-flares, at admission. Traditional approaches were then compared with informatic techniques. RESULTS: Among 420 SLE patients of the cohort, 114 flares occurred between 2015 and 2021; 79 extra-renal flares, predominantly mucocutaneous (24.1%) and musculoskeletal (45.6%), were considered. After 12 months, 79.4% and 49.4% were in LLDAS and in remission, respectively, while 17 flares were classified as D2T (21.5%); D2T flares received a higher cumulative and daily dose of glucocorticoids. Among the clusters, cluster 'D' (mild-moderate flares with mucocutaneous manifestations in patients with history of skin involvement) was associated with the lowest rate of remission. Among clinical data, not being on LLDAS at 3 months was the unique independent predictor of D2T flares. CONCLUSIONS: Our clusterization well separates extra-renal flares according to their baseline features and may propose a new identification standard. D2T flares, especially refractory skin manifestations, are frequent in SLE and represent an unmet need in the management of the disease as they are associated with higher glucocorticoid (GC) dosage and risk of damage accrual. Our ML model could help in the early identification of D2T flares, flagging them to elevate the attention threshold at admission.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Maffi M, Tani C, Cascarano G, et al. Which extra-renal flare is 'difficult to treat' in systemic lupus erythematosus? A one-year longitudinal study comparing traditional and machine learning approaches. Rheumatology (Oxford). 2024. PMID: 37094218. doi:10.1093/rheumatology/kead166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。